All Articles

Freedom Holding Corp. posts a 40% revenue jump but a drop in net income, signaling an aggressive, high-cost strategy centered on its SuperApp and major acquisitions.

Khloé Kardashian's Khloud launches a collagen-infused protein chip exclusively at Walmart, revealing a sophisticated strategy to dominate the functional food boom.

While digital payments capture the spotlight, a silent tech revolution is securing physical currency. This is not about simple counting; it's about survival.

A shocking $90M guidance cut and a securities probe at Myriad Genetics reveal more than a bad quarter; they expose deep cracks in the genetic testing market.

AGCO's stock plunged after a surprise guidance cut, triggering a legal probe. We dissect if this was just a market downturn or a failure in transparency.

A retired engineer’s life was shattered by one illegal turn. A $2.8M settlement offers accountability but raises questions about traffic safety and justice.

A landmark deal between AI startup Netic and services giant ARS reveals a new playbook for scaling operations without sacrificing the human touch.

Bristol Myers Squibb's massive Texas campus isn't just about jobs. It's a high-tech play to reshore drug manufacturing and revolutionize how we make medicine.

EveryPlate's new campaign with Emily Oster isn't just about selling meals. It's a calculated strategy to solve the 'invisible load' of dinner for parents.

How Potomac Fund Management leveraged risk management and relentless reinvestment to surge from $140M to $5B AUM, rewriting the playbook for modern growth.

The abrupt exit of President Heather Dixon and the return of a former COO raises critical questions about stability and long-term strategy at the home care giant.

A major shift in self-care is underway, with new data showing consumers are erasing the line between sexual wellness, beauty, and their daily supplement regimen.

Cowboy Space hires a top Oracle sales exec, signaling its audacious plan for orbital data centers is open for business. Is this the dawn of AI's final frontier?

With the hire of Preeti Shukla, Brightfin isn't just adding a feature. It's betting its future on agentic AI to proactively manage enterprise tech spend.

Miami-based Gencom restructures into two distinct units, sharpening its focus on investment and execution to scale its $8 billion luxury real estate empire.

As AI giants build generalist deployment arms, Harbor bets on a specialist approach for law, aiming to solve the industry's unique adoption challenges.

With its 30th Illinois clinic, Westside Children's Therapy brings its integrated pediatric care model to Peoria, addressing a growing need for services.

The nonprofit's acquisition of Aselo isn't just a tech upgrade. It's a calculated move to build the foundational infrastructure for global crisis response.

In a strategic move, Xcellon acquires a GMP facility, aiming to become a key CRDMO for complex biologics and bolster America's biotech supply chain.

Former World Bank President Dr. Jim Yong Kim joins ImmunityBio. Is this a new model for biotech social impact or a high-stakes bet on global expansion?